Pharmaceutical Janssen, the prescription medicines business of US healthcare giant Johnson & Johnson, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion to update the Invokana (canagliflozin) and Vokanamet (canagliflozin and metformin) labels including changes to the indication statements. 2 August 2018